1,2,3‐Triazole hybrids as anticancer agents: A review
Publication type: Journal Article
Publication date: 2021-09-24
scimago Q2
wos Q2
SJR: 0.571
CiteScore: 7.0
Impact factor: 3.6
ISSN: 03656233, 15214184
PubMed ID:
34559414
Drug Discovery
Pharmaceutical Science
Abstract
Despite the advancements in the development of anticancer agents, more effective and safer anticancer drugs still need to be developed as the current agents cause unwanted side effects and many patients have become drug resistant. 1,2,3‐Triazoles, due to their remarkable biological potential, have received considerable attention in drug discovery for the development of anticancer agents. The present review article presents an overview of the recent advances in 1,2,3‐triazole hybrids with anticancer potential over the last 2 years, their chemical structures, structure–activity relationships, and mechanisms of action, as well as insights into the docking studies.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
5
10
15
20
25
30
|
|
|
Journal of Molecular Structure
27 publications, 11.11%
|
|
|
ChemistrySelect
14 publications, 5.76%
|
|
|
Archiv der Pharmazie
10 publications, 4.12%
|
|
|
New Journal of Chemistry
9 publications, 3.7%
|
|
|
European Journal of Medicinal Chemistry
9 publications, 3.7%
|
|
|
Bioorganic Chemistry
9 publications, 3.7%
|
|
|
Polycyclic Aromatic Compounds
9 publications, 3.7%
|
|
|
Molecules
8 publications, 3.29%
|
|
|
Russian Journal of Bioorganic Chemistry
6 publications, 2.47%
|
|
|
International Journal of Molecular Sciences
5 publications, 2.06%
|
|
|
Chemistry and Biodiversity
5 publications, 2.06%
|
|
|
Scientific Reports
4 publications, 1.65%
|
|
|
Medicinal Chemistry Research
4 publications, 1.65%
|
|
|
RSC Advances
4 publications, 1.65%
|
|
|
Russian Journal of General Chemistry
4 publications, 1.65%
|
|
|
Future Medicinal Chemistry
4 publications, 1.65%
|
|
|
Results in Chemistry
4 publications, 1.65%
|
|
|
Molecular Diversity
4 publications, 1.65%
|
|
|
Applied Organometallic Chemistry
3 publications, 1.23%
|
|
|
European Journal of Organic Chemistry
3 publications, 1.23%
|
|
|
Journal of Biomolecular Structure and Dynamics
3 publications, 1.23%
|
|
|
Pharmaceuticals
3 publications, 1.23%
|
|
|
Organic and Biomolecular Chemistry
2 publications, 0.82%
|
|
|
Steroids
2 publications, 0.82%
|
|
|
Asian Journal of Organic Chemistry
2 publications, 0.82%
|
|
|
ChemMedChem
2 publications, 0.82%
|
|
|
Journal of Enzyme Inhibition and Medicinal Chemistry
2 publications, 0.82%
|
|
|
Natural Product Research
2 publications, 0.82%
|
|
|
Reactions
2 publications, 0.82%
|
|
|
5
10
15
20
25
30
|
Publishers
|
10
20
30
40
50
60
70
80
|
|
|
Elsevier
73 publications, 30.04%
|
|
|
Wiley
45 publications, 18.52%
|
|
|
MDPI
27 publications, 11.11%
|
|
|
Taylor & Francis
23 publications, 9.47%
|
|
|
Royal Society of Chemistry (RSC)
22 publications, 9.05%
|
|
|
Springer Nature
22 publications, 9.05%
|
|
|
Pleiades Publishing
12 publications, 4.94%
|
|
|
American Chemical Society (ACS)
5 publications, 2.06%
|
|
|
Frontiers Media S.A.
4 publications, 1.65%
|
|
|
Bentham Science Publishers Ltd.
4 publications, 1.65%
|
|
|
Hindawi Limited
1 publication, 0.41%
|
|
|
IOP Publishing
1 publication, 0.41%
|
|
|
Walter de Gruyter
1 publication, 0.41%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.41%
|
|
|
Asian Journal of Chemistry
1 publication, 0.41%
|
|
|
10
20
30
40
50
60
70
80
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
244
Total citations:
244
Citations from 2024:
145
(59.68%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Alam M. M. 1,2,3‐Triazole hybrids as anticancer agents: A review // Archiv der Pharmazie. 2021. Vol. 355. No. 1. p. 2100158.
GOST all authors (up to 50)
Copy
Alam M. M. 1,2,3‐Triazole hybrids as anticancer agents: A review // Archiv der Pharmazie. 2021. Vol. 355. No. 1. p. 2100158.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1002/ardp.202100158
UR - https://doi.org/10.1002/ardp.202100158
TI - 1,2,3‐Triazole hybrids as anticancer agents: A review
T2 - Archiv der Pharmazie
AU - Alam, Mohammad Mahboob
PY - 2021
DA - 2021/09/24
PB - Wiley
SP - 2100158
IS - 1
VL - 355
PMID - 34559414
SN - 0365-6233
SN - 1521-4184
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Alam,
author = {Mohammad Mahboob Alam},
title = {1,2,3‐Triazole hybrids as anticancer agents: A review},
journal = {Archiv der Pharmazie},
year = {2021},
volume = {355},
publisher = {Wiley},
month = {sep},
url = {https://doi.org/10.1002/ardp.202100158},
number = {1},
pages = {2100158},
doi = {10.1002/ardp.202100158}
}
Cite this
MLA
Copy
Alam, Mohammad Mahboob. “1,2,3‐Triazole hybrids as anticancer agents: A review.” Archiv der Pharmazie, vol. 355, no. 1, Sep. 2021, p. 2100158. https://doi.org/10.1002/ardp.202100158.